Suzuki S, Kuroume T
Int Arch Allergy Appl Immunol. 1977;53(6):498-504. doi: 10.1159/000231791.
Homocytotrophic antibodies (HCA) were produced in rats by primary injection of streptokinase-streptodornase (SK-SD) after the antigen was absorbed on alminum hydroxide gel. The properties of rat SK-SD-specific HCA were qualitatively similar to SK-SD skin-sensitizing antibodies found in sera of human beings, namely, homocytotropic activity (48 h homologous PCA reaction), heat lability at 56 degrees C, and inactivation by reduction with 2-mercaptoethanol followed by alkylation with iodoacetamide. In neutralization tests, D-SK-SD, a low molecular hapten-like substance contained in SK-SD preparation, absorbed the antibody against ND-SK-SD antigen-specifically. The neutralizing activity mostly resided in fraction 1 of D-SK-SD separated through DEAE-Sephadex A-25 ion-exchange column, opposing the inhibitory activity of fraction 3 on lymphocyte transformation. The possible implication of these findings in the immunological treatment of streptococcal disorders is discussed.
在抗原吸附于氢氧化铝凝胶上后,通过初次注射链激酶 - 链道酶(SK - SD)在大鼠体内产生了亲同种细胞抗体(HCA)。大鼠SK - SD特异性HCA的特性在质量上与人血清中发现的SK - SD皮肤致敏抗体相似,即亲同种细胞活性(48小时同源PCA反应)、56℃热不稳定性以及用2 - 巯基乙醇还原后再用碘乙酰胺烷基化使其失活。在中和试验中,SK - SD制剂中含有的低分子半抗原样物质D - SK - SD特异性地吸收了针对ND - SK - SD抗原的抗体。中和活性主要存在于通过DEAE - 葡聚糖A - 25离子交换柱分离的D - SK - SD的第1部分,这与第3部分对淋巴细胞转化的抑制活性相反。讨论了这些发现对链球菌疾病免疫治疗的可能意义。